Lower prevalence of Helicobacter pylori infection in patients with inflammatory bowel disease but not with chronic obstructive pulmonary disease-antibiotic use in the history does not play a significant role

被引:40
|
作者
Prónai, L [1 ]
Schandl, L
Orosz, Z
Magyar, P
Tulassay, Z
机构
[1] Semmelweis Univ, Hungarian Acad Sci, Fac Med, Dept Med 2,Gastroenterol Res Unit, Budapest, Hungary
[2] Semmelweis Univ, Dept Pulmonol, H-1088 Budapest, Hungary
关键词
Helicobacter pylori; inflammatory bowel disease; Crohn's disease; ulcerative colitis; chronic obstructive pulmonary disease;
D O I
10.1111/j.1083-4389.2004.00223.x
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background. Patients with inflammatory bowel disease have lower prevalence of Helicobacter pylori infection, but the exact reason for this is not yet clear. Aim. To examine whether the antibiotics frequently used in inflammatory bowel disease are responsible for the lower prevalence of H. pylori infection. Patients with chronic obstructive pulmonary disease on prolonged previous antibiotic therapy were used for comparison. Methods. Presence/absence of H. pylori infection was detected by a C-13-urea breath test in 133 patients with inflammatory bowel disease (82 ulcerative colitis, and 51 Crohn's disease) and compared with that of 135 patients with chronic obstructive pulmonary disease and with two age-matched control groups (200 patients each). Primary disease location, duration of disease and detailed analysis of previous and current medication (dose and duration of antibiotics, steroids, 5-aminosalicylic acid) were analysed in each cases. Results. Seventeen of the 133 patients with inflammatory bowel disease [12.2% (10/82) of ulcerative colitis and 13.7% (7/51) of Crohn's disease] and 90/135 patients with chronic obstructive pulmonary disease (66.7%) were positive for H. pylori. A total of 78/200 (39%) for the inflammatory-bowel-discase-group-matched controls and 110/210 (55%) for the chronic-obstructive-pulmonary-disease-matched controls were positive for H. pylori. The history of any antibiotic or steroid therapy had no influence on H. pylori status of patients with inflammatory bowel disease. Conclusion. The prevalence of H. pylori compared to the age-matched controls is significantly lower in patients with inflammatory bowel disease but not in those with chronic obstructive pulmonary disease. Antibiotic use is not responsible for the lower prevalence of H. pylori infection in patients with inflammatory bowel disease.
引用
收藏
页码:278 / 283
页数:6
相关论文
共 50 条
  • [31] The prevalence of Helicobacter pylori infection in inflammatory bowel disease in China: A case-control study
    Ding, Zhao-Hui
    Xu, Xiao-Ping
    Wang, Tian-Rong
    Liang, Xiao
    Ran, Zhi-Hua
    Lu, Hong
    PLOS ONE, 2021, 16 (03):
  • [32] Eradication of Helicobacter pylori in Patients with Inflammatory Bowel Disease for Prevention of Recurrences - Impact on the Natural History of the Disease
    Varas Lorenzo, Modesto
    Munoz Age, Fernando
    Sanchez-Vizcaino Mengual, Elena
    EURASIAN JOURNAL OF MEDICINE AND ONCOLOGY, 2019, 3 (01): : 59 - 65
  • [33] Helicobacter pylori-positive gastritis in pediatric patients with chronic inflammatory bowel disease
    Kolho, KL
    Rautelin, H
    Lindahl, H
    Savilahti, E
    JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 1998, 27 (03): : 292 - 295
  • [34] Does Race Play a Role in Medication Adherence in Inflammatory Bowel Disease Patients?
    Clermont, Michelle P.
    Mandalia, Amar B.
    Gardner, Doree
    Farraye, Francis A.
    Iskandar, Heba
    GASTROENTEROLOGY, 2015, 148 (04) : S833 - S833
  • [35] Helicobacter pylori seroprevalence in patients with chronic obstructive pulmonary disease and its relation to pulmonary function tests
    Gencer, Mehmet
    Ceylan, Erkan
    Zeyrek, Fadile Yildiz
    Aksoy, Nurten
    RESPIRATION, 2007, 74 (02) : 170 - 175
  • [36] Role of Helicobacter pylori infection in peptic ulcer in patients with chronic liver disease
    Gisbert, JP
    Moreno-Otero, R
    Pajares, JM
    GUT, 2002, 51 : A63 - A63
  • [37] Over-time changes of Helicobacter pylori infection rate in patients with inflammatory bowel disease
    Triantafillidis, John K.
    Gikas, Aristofanis
    JOURNAL OF CROHNS & COLITIS, 2013, 7 (08): : 681 - 681
  • [38] PREVALENCE AND OUTCOME OF ACUTE PULMONARY EMBOLISM IN PATIENTS WITH A HISTORY OF INFLAMMATORY BOWEL DISEASE
    Iourinets, Julia
    Desai, Parth
    Sutherland, David
    Shah, Parth
    Bruno, Elizabeth
    Arora, Punit
    Malik, Muhammad
    Patel, Axat
    Akhtar, Tauseef
    Fareed, Jawed
    Brailovsky, Yevgeniy
    Naik, Amar
    Darki, Amir
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2023, 81 (08) : 2048 - 2048
  • [39] Antibiotic use and risk of Clostridioides difficile infection in patients with inflammatory bowel disease
    Bejcek, Alexis
    Ancha, Anupama
    Lewis, Megan
    Beaver, Ryan
    Tecson, Kristen
    Bomar, Jaccallene
    Johnson, Christopher
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2024, 39 (11) : 2417 - 2423
  • [40] ANTIBIOTIC USE AND RISK OF CLOSTRIDIOIDES DIFFICILE INFECTION IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE
    Bejcek, Alexis
    Ancha, Anupama
    Lewis, Megan
    Johnson, Christopher
    GASTROENTEROLOGY, 2022, 162 (07) : S996 - S997